Immunogen Inc (IMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 14,162 | 38,078 | 27,992 | 9,210 | 16,948 |
| Gross Profit | 14,162 | 38,078 | 27,992 | 9,210 | 16,948 |
| Operating Expenses | 75,215 | 60,930 | 62,546 | 43,444 | 44,317 |
| Operating Income | -61,053 | -22,852 | -34,554 | -34,234 | -27,369 |
| Interest Expense | 1,078 | 1,249 | 2,151 | 2,751 | 3,580 |
| Other Income | 110 | -44 | -467 | -354 | 208 |
| Pre-tax Income | -62,021 | -24,145 | -37,172 | -37,339 | -30,741 |
| Net Income Continuous | -62,021 | -24,145 | -37,172 | -37,339 | -30,741 |
| Net Income | $-62,021 | $-24,145 | $-37,172 | $-37,339 | $-30,741 |
| EPS Basic Total Ops | -0.24 | -0.10 | -0.18 | -0.18 | -0.15 |
| EPS Basic Continuous Ops | -0.24 | -0.10 | -0.17 | -0.18 | -0.15 |
| EPS Diluted Total Ops | -0.24 | -0.10 | -0.18 | -0.18 | -0.15 |
| EPS Diluted Continuous Ops | -0.24 | -0.10 | -0.17 | -0.18 | -0.15 |
| EPS Diluted Before Non-Recurring Items | -0.24 | -0.10 | -0.17 | N/A | N/A |
| EBITDA(a) | $-60,595 | $-22,379 | $-34,092 | $-33,772 | $-26,827 |